4/13/20 4/13/20

Balancing immunity and inflammation in lung disease

Resources for both preventing serious infection and preventing damage to the lungs by the inflammation that fights infection in COVID-19 are considered.

11/6/14 11/6/14

Hair loss frequently associated with autoimmunity

Identifying hair loss as associated with early immune system dysregulation not only permits proper treatment of the presenting complaint but becomes an opportunity to ward off progression to more debilitating autoimmune disease.

2/27/14 2/27/14

Bipolar disorder and neuroinflammation

There is a massive amount of evidence supporting the importance of assessing and treating neuroinflammation in bipolar disorder and other neuropsychiatric illnesses. This makes necessarily the comprehensive examination of autoimmunity and its numerous underlying contributory causes.

5/19/13 5/19/13

Prof. Y. Shoenfeld talks about ASIA: autoimmune syndrome induced by vaccine adjuvants

Professor Yehuda Shoenfeld of the Zabludowicz Center for Autoimmune Diseases, Tel-Aviv University talks on ASIA—autoimmune sydrome induced by adjuvants (used to magnify the immune response to vaccines). He does not argue against the immense benefits of vaccines, but explains briefly why clinicians must be aware of the potential for autoimmune complications in a percentage of the population that may be predisposed. Morever, he discusses how the process in ASIA is relevant also for the loss of tolerance involved in conditions such as environmental and chemical sensitivity, chronic fatigue syndrome (CFS), fibromyalgia, narcolepsy, sick building syndrome, reactions to silicon implants, Gulf War syndrome and others.

5/16/13 5/16/13

Depression, aging and brain inflammation: indications for sustainable treatment

Depression and aging, not only diminished cognitive function but the level of physiological competence throughout the body, have brain inflammation in common. This fact is of premiere importance when designing rational treatment plans for both depression and high functioning longevity.

5/6/13 5/6/13

Type 1 diabetes and cytokines: clinical opportunities

Type 1 diabetes, like all autoimmune diseases, is characterized by dysregulated pro-inflammatory and anti-inflammatory cytokines. Recent studies that reveal the dynamics suggest opportunities for therapy.